Tower Research Capital LLC (Trc) Leap Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.29 - $0.72 $4,328 - $10,746	-14,925 Reduced 87.75%	2,083 $1,000
Q4 2022 Feb 10, 2023	BUY	$0.42 - $0.78 $3,651 - $6,782	8,695 Added 104.6%	17,008 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.92 - $1.75 $3,852 - $7,327	4,187 Added 101.48%	8,313 $7,000
Q2 2022 Aug 15, 2022	BUY	$0.96 - $1.91 $968 - $1,927	1,009 Added 32.37%	4,126 $5,000
Q1 2022 May 12, 2022	BUY	$1.6 - $3.35 $4,899 - $10,257	3,062 Added 5567.27%	3,117 $5,000

Q4 2021 Feb 14, 2022	SELL	$2.08 - $3.65 $158,662 - $278,422	-76,280 Reduced 99.93%	55 $0
Q3 2021 Nov 15, 2021	BUY	$1.35 - $4.01 $101,383 - $301,146	75,099 Added 6075.97%	76,335 $307,000
Q2 2021 Aug 16, 2021	SELL	$1.48 - $1.92 $14,942 - $19,384	-10,096 Reduced 89.09%	1,236 $2,000
Q1 2021 May 17, 2021	BUY	$1.82 - $3.01 $20,624 - $34,109	11,332 New	11,332 $22,000
Q4 2020 Feb 16, 2021	SELL	$1.49 - $2.37 $4,768 - $7,584	-3,200 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.68 - $2.17 $52,471 - $67,775	-31,233 Reduced 90.71%	3,200 $6,000
Q2 2020 Aug 13, 2020	BUY	$1.39 - $2.84 $47,861 - $97,789	34,433 New	34,433 $72,000
Q4 2018 Feb 14, 2019	SELL	$1.92 - $7.94 $1,925 - $7,963	-1,003 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.52 - $9.13 $6,539 - $9,157	1,003 New	1,003 $8,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $198M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.